Tighe Wilhelmy here with Velawcity to discuss significant developments in the ongoing Essure litigation. Brief refresher, Essure is a medical device manufactured by Bayer to serve as a permanent form of birth control. This device was FDA approved in 2002 and has been subject to much controversy because of over 10,000 reported injuries filed by women in North America. The United States is where most of the 750,000 women with Essure devices reside.
However, this device has been banned in Brazil (ban lifted on July 10th, 2017) and discontinued in both Finland and the United Kingdom. And the most recent development was Bayer’s voluntary discontinuation of Essure device sales in Canada, where there happens to be a pending class-action lawsuit involving 297 women, many of which underwent hysterectomies. According to Bayer, declining sales was the reason behind the decision to discontinue sales in Canada. They even went on to reiterate the risk-benefit profile of Essure has not changed. It remains to be seen whether or not this will impact the ongoing Essure litigation here in the United States.
For more information regarding the Essure litigation, including case acquisition, please visit our website or give us a call. I’m Tighe Wilhelmy and thanks for watching.